Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations
Journal of Clinical Medicine · 11.11.2025 · 14 (22) · 7984
DOI: 10.3390/jcm14227984 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.11.2025. Verfasst von Antonio M Caballero-Mateos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gastroenterology Unit, Hospital Santa Ana, 18600 Motril, Spain. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) management traditionally focuses on intestinal inflammation, yet extraintestinal manifestations can substantially impair patient quality of life. In this perspective, we emphasize the broad systemic impact of IBD—from highly prevalent conditions such as anemia, metabolic dysfunction-associated steatotic liver disease, or fatigue to rare but severe complications like interstitial lung disease and drug-induced glomerulonephritis. We review underlying mechanisms linking gut inflammation to distant organs, including immune dysregulation, microbial translocation, and metabolic derangements. Advances in diagnostics—such as biomarker panels, high-resolution imaging, and genomic/microbiome profiling—enable early detection and risk stratification. Emerging therapies, including targeted biologics (anti-TNF, anti-integrin, anti-IL-23), JAK and S1P modulators, precision nutrition, and microbiome modulation, offer new opportunities to address systemic inflammation. A multidisciplinary framework integrating gastroenterology with hepatology, hematology, neurology, nephrology, endocrinology, dermatology, pulmonology, and cardiology is essential to recognize hidden complications, facilitate timely intervention, and deliver personalized, comprehensive care for IBD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Gastroenterology Unit, Hospital Santa Ana, 18600 Motril, Spain.
- Institute of Biosanitary Research (IBS) Precision Medicine, 18012 Granada, Spain.
- Gastroenterology Department, Parc Taulí University Hospital, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Department of Gastroenterology and Hepatology, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research (IMIBIC), University of Cordoba, 14004 Cordoba, Spain.
ORCID-Profile: Antonio M Caballero-Mateos, Eduard Brunet-Mas, Beatriz Gros
Zitieren
APA
Caballero-Mateos, A. M., Brunet-Mas, E., & Gros, B. (2025). Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine, 14(22), 7984. https://doi.org/10.3390/jcm14227984
Vancouver
Caballero-Mateos AM, Brunet-Mas E, Gros B. Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations. Journal of Clinical Medicine. 2025;14(22):7984. doi:10.3390/jcm14227984
BibTeX
@article{CaballeroMateos2025,
author = {Caballero-Mateos, Antonio M and Brunet-Mas, Eduard and Gros, Beatriz},
title = {Systemic Consequences of Inflammatory Bowel Disease Beyond Immune-Mediated Manifestations},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {22},
pages = {7984},
doi = {10.3390/jcm14227984}
}
EUVIMED